High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.

MeSH Terms: Adolescent, Adult, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Bone Marrow Purging, Cisplatin, Combined Modality Therapy, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Drug Administration Schedule, Female, Follow-Up Studies, Forecasting, Graft Survival, Hematopoietic Stem Cell Transplantation, Humans, Leucovorin, Lymphoma, Non-Hodgkin, Male, Methotrexate, Middle Aged, Prednisone, Remission Induction, Risk Factors, Rituximab, Survival Analysis, Transplantation Conditioning, Treatment Outcome, Vincristine